Skip to main content
Signal8

Lundgren Erik

SEC insider (Form 3/4/5 filer). CIK 0002137540. Chief Executive Officer at IMMUNIC, INC. (IMUX). 1 reported Form 4/5 transaction since Sep 2024; latest on May 22, 2026. Located in NEW YORK, NY.

Companies Lundgren Erik has filed insider reports for

  • IMMUNIC, INC. (IMUX): Officer, Chief Executive Officer
Lundgren Erik profile photo

Lundgren Erik

CIK: 0002137540

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IMMUNIC, INC. logo
IMUX

IMMUNIC, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • IMMUNIC, INC. logo
    IMUX

    IMMUNIC, INC.

    May 22, 2026
    Award

    Stock Option

    Direct
    1M shares-

1-1 of 1